The global recombinant vaccines market size is expected to reach USD 25.32 billion by 2027, exhibiting a CAGR of 11.3% ****ween 2019 to 2027. The introduction of innovative recombinant vaccines owing to the incidence of several infectious viruses such as coronavirus and hepatitis B will uplift the market potential during the forecast period, The market size stood at USD 10.82 billion in 2019.

For More Information: